Sera Prognostics首席财务官出售价值USD 19,850股份
Sera Prognostics, Inc.（NASDAQ:SERA）首席财务官Austin Aerts于2025年3月7日进行了一笔交易，出售了4,818股公司A类普通股。此次大额交易的总价值约为USD 19,850，股票加权平均售价为USD 4.12，交易价格区间在USD 4.02至USD 4.33之间。此次出售发生之际，SERA股票年初至今已下跌近47%，当前价格与其52周高点USD ...
Sera Prognostics首席科学官出售价值$8,503股票
盐湖城讯—市值1.46亿美元、目前股价为$4.32的Sera Prognostics, Inc.（NASDAQ:SERA）近期出现内部人士交易活动。根据Form 4文件显示，公司首席科学官John J. Boniface于2025年3月6日以每股$4.16的加权平均价格出售了2,044股A类普通股，总计$8,503。 InvestingPro ...
美股内部交易 | Sera Prognostics于3月10日披露3笔公司内部人交易情况
2025年3月10日， Sera Prognostics（SERA）披露3笔公司内部人交易情况。董事Lindgardt Zhenya于2025年3月7日卖出2.97万股。 Sera Prognostics, Inc.于2008年1月17日根据特拉华州法律注册成立。该公司是一家女性健康诊断公司，利用公司专有的蛋白质组学和生物信息学平台来发现、开发和商业化具有临床意义和经济影响的生物标志物测试 ...
来自MSN1 个月
Sera Prognostics dips 5%, prices $50M offering
Sera Prognostics (NASDAQ:SERA) priced its underwritten public offering of 1.25M shares at a public offering price of $4.00 per share, pre-funded warrants to purchase 11.25M shares at $3.9999 per ...
来自MSN1 个月
Sera Prognostics CFO sells $27,090 in stock
SALT LAKE CITY—Aerts Austin, the Chief Financial Officer of Sera Prognostics , Inc. (NASDAQ:SERA), a company with a market capitalization of $137.45 million, executed a stock sale valued at ...
ETF Daily News6 天
Sera Prognostics (SERA) to Release Quarterly Earnings on Wednesday
Sera Prognostics has a 12 month low of $3.84 and a 12 month high of $12.36. The stock has a market capitalization of $142.52 million, a PE ratio of -4.26 and a beta of 0.89.
Wall Street Journal1 个月
Sera Prognostics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Wall Street Journal1 个月
Sera Prognostics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
CNN2 年
Sera Prognostics, Inc. Class A
Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm ...
Investing11 天
Sera Prognostics at TD Cowen: Innovative Approaches to Preterm Birth
On Wednesday, 05 March 2025, Sera Prognostics (NASDAQ: SERA) participated in the TD Cowen 45th Annual Healthcare Conference, where President and CEO Zaina Lingard discussed the company’s ...
Nasdaq25 天
Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy ...